close
Asian(H)

BioTime’s Renevia succeeds in pivotal European facial wasting trial

reuters125-ca2bfe880cfaf1d7cb9394a7274d50479b0c4e0b

(Reuters) – BioTime Inc said on Wednesday its Renevia system succeeded in meeting the main goal of a pivotal European trial for facial wasting associated with treatment for HIV, putting it on track to file for European approval this year.

admin

The author admin

Leave a Response